San Francisco, United States
Abridge, founded in 2018, stands at the forefront of healthcare innovation, leveraging AI to enhance clinical documentation. Recognized as the "#1 Best in KLAS" for Enterprise-grade Ambient AI, Abridge focuses on improving the efficiency of medical conversations by transforming them into structured clinical notes in real-time. This advancement allows clinicians to prioritize patient care.
With its deep EMR integrations and auditable AI, Abridge is unique in its ability to map AI-generated summaries to ground truth. This verification process is crucial for building trust among healthcare providers. Positioned in the United States, Abridge is a pioneer in setting industry standards for responsible AI deployment within health systems.
The company attracted significant attention with a $300.00M Series E investment on June 25, 2025, backed by renowned investors Khosla Ventures and Andreessen Horowitz. Abridge's strategic focus on AI, Health Care, and Machine Learning underscores its potential to reshape healthcare delivery.
ClosedLoop
ChartWise Medical Systems, Inc.